Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Beavis

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Experimental Medicine|June 6, 2000
In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramersK Benlagha, A Weiss, A Beavis, et al.
Current Opinion in Pharmacology|May 23, 2016
Immunosuppressive activities of adenosine in cancerBertrand Allard, Paul A Beavis, Phillip K Darcy, et al.
Science Translational Medicine|June 7, 2019
Supercharging adoptive T cell therapy to overcome solid tumor-induced immunosuppressionSherly Mardiana, Benjamin J Solomon, Phillip K Darcy, et al.
Current Opinion in Pharmacology|August 28, 2020
Pharmacological and genetic strategies for targeting adenosine to enhance adoptive T cell therapy of cancerKevin Sek, Lev M Kats, Phillip K Darcy, et al.
Cancer Cell|November 5, 2021
Adoptive transfer of tumor-specific Th9 cells eradicates heterogeneous antigen-expressing tumor cellsKevin Sek, Cheok Weng Chan, Paul A Beavis, et al.
Trends in Immunology|April 11, 2012
CD73: a potent suppressor of antitumor immune responsesPaul A Beavis, John Stagg, Phillip K Darcy, et al.
Forensic Science International|November 28, 2016
Current perspectives in the interpretation of gunshot residues in forensic science: A reviewM Maitre, K P Kirkbride, M Horder, et al.
Nature Reviews. Drug Discovery|September 15, 2020
Targeting the epigenetic regulation of antitumour immunitySimon J Hogg, Paul A Beavis, Mark A Dawson, et al.
Spine|June 1, 1991
An analysis of normal back shape measured by ISIS scanningA J Carr, R J Jefferson, A R Turner-Smith, et al.
Immunology and Cell Biology|March 21, 2022
CD4<sup>+</sup> chimeric antigen receptor T cells in for the long journeyAmanda Xy Chen, Emily B Derrick, Paul A Beavis, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Experimental Medicine|June 6, 2000
In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramersK Benlagha, A Weiss, A Beavis, et al.
Current Opinion in Pharmacology|May 23, 2016
Immunosuppressive activities of adenosine in cancerBertrand Allard, Paul A Beavis, Phillip K Darcy, et al.
Science Translational Medicine|June 7, 2019
Supercharging adoptive T cell therapy to overcome solid tumor-induced immunosuppressionSherly Mardiana, Benjamin J Solomon, Phillip K Darcy, et al.
Current Opinion in Pharmacology|August 28, 2020
Pharmacological and genetic strategies for targeting adenosine to enhance adoptive T cell therapy of cancerKevin Sek, Lev M Kats, Phillip K Darcy, et al.
Cancer Cell|November 5, 2021
Adoptive transfer of tumor-specific Th9 cells eradicates heterogeneous antigen-expressing tumor cellsKevin Sek, Cheok Weng Chan, Paul A Beavis, et al.
Trends in Immunology|April 11, 2012
CD73: a potent suppressor of antitumor immune responsesPaul A Beavis, John Stagg, Phillip K Darcy, et al.
Forensic Science International|November 28, 2016
Current perspectives in the interpretation of gunshot residues in forensic science: A reviewM Maitre, K P Kirkbride, M Horder, et al.
Nature Reviews. Drug Discovery|September 15, 2020
Targeting the epigenetic regulation of antitumour immunitySimon J Hogg, Paul A Beavis, Mark A Dawson, et al.
Spine|June 1, 1991
An analysis of normal back shape measured by ISIS scanningA J Carr, R J Jefferson, A R Turner-Smith, et al.
Immunology and Cell Biology|March 21, 2022
CD4<sup>+</sup> chimeric antigen receptor T cells in for the long journeyAmanda Xy Chen, Emily B Derrick, Paul A Beavis, et al.
Pageof 10